The role of cytomegalovirus in angiogenesis
- PMID: 20869406
- PMCID: PMC3040784
- DOI: 10.1016/j.virusres.2010.09.011
The role of cytomegalovirus in angiogenesis
Abstract
Human cytomegalovirus (HCMV) infection has been associated with the acceleration of vascular disease including atherosclerosis and transplant associated vasculopathy in solid organ transplants. HCMV promotes vascular disease at many of the different stages of the disease development. These include the initial injury phase, enhancing the response to injury and inflammation, as well as by increasing SMC hyperplasia and foamy macrophage cell formation. Angiogenesis is a critical process involved in the development of vascular diseases. Recently, HCMV has been shown to induce angiogenesis and this process is thought to contribute to HCMV-accelerated vascular disease and may also be important for HCMV-enhanced tumor formation. This review will highlight the role of HCMV in promoting angiogenesis.
Copyright © 2010 Elsevier B.V. All rights reserved.
Figures
Similar articles
-
Direct infection of primary endothelial cells with human cytomegalovirus prevents angiogenesis and migration.J Gen Virol. 2015 Dec;96(12):3598-3612. doi: 10.1099/jgv.0.000301. J Gen Virol. 2015. PMID: 26416316
-
Mechanisms of cytomegalovirus-accelerated vascular disease: induction of paracrine factors that promote angiogenesis and wound healing.Curr Top Microbiol Immunol. 2008;325:397-415. doi: 10.1007/978-3-540-77349-8_22. Curr Top Microbiol Immunol. 2008. PMID: 18637518 Free PMC article. Review.
-
Human cytomegalovirus-encoded miR-UL112 contributes to HCMV-mediated vascular diseases by inducing vascular endothelial cell dysfunction.Virus Genes. 2018 Apr;54(2):172-181. doi: 10.1007/s11262-018-1532-9. Epub 2018 Jan 12. Virus Genes. 2018. PMID: 29330663
-
Human cytomegalovirus productively infects lymphatic endothelial cells and induces a secretome that promotes angiogenesis and lymphangiogenesis through interleukin-6 and granulocyte-macrophage colony-stimulating factor.J Gen Virol. 2011 Mar;92(Pt 3):650-60. doi: 10.1099/vir.0.025395-0. Epub 2010 Dec 1. J Gen Virol. 2011. PMID: 21123547
-
Human cytomegalovirus infection and coronary heart disease: a systematic review.Virol J. 2018 Feb 6;15(1):31. doi: 10.1186/s12985-018-0937-3. Virol J. 2018. PMID: 29409508 Free PMC article. Review.
Cited by
-
Cytomegalovirus seropositivity is associated with increased arterial stiffness in patients with chronic kidney disease.PLoS One. 2013;8(2):e55686. doi: 10.1371/journal.pone.0055686. Epub 2013 Feb 25. PLoS One. 2013. PMID: 23451030 Free PMC article.
-
Human Cytomegalovirus UL135 and UL136 Genes Are Required for Postentry Tropism in Endothelial Cells.J Virol. 2015 Jul;89(13):6536-50. doi: 10.1128/JVI.00284-15. Epub 2015 Apr 15. J Virol. 2015. PMID: 25878111 Free PMC article.
-
Cytomegalovirus: Shape-Shifting the Immune System.J Immunol. 2018 Jun 15;200(12):3881-3889. doi: 10.4049/jimmunol.1800171. J Immunol. 2018. PMID: 29866770 Free PMC article. Review.
-
Overview of Human Cytomegalovirus Pathogenesis.Methods Mol Biol. 2021;2244:1-18. doi: 10.1007/978-1-0716-1111-1_1. Methods Mol Biol. 2021. PMID: 33555579 Review.
-
The human cytomegalovirus lytic cycle is induced by 1,25-dihydroxyvitamin D3 in peripheral blood monocytes and in the THP-1 monocytic cell line.Virology. 2015 Sep;483:83-95. doi: 10.1016/j.virol.2015.04.004. Epub 2015 May 15. Virology. 2015. PMID: 25965798 Free PMC article.
References
-
- Almond PS, Matas A, Gillingham K, Dunn DL, Payne WD, Gores P, Gruessner R, Najarian JS. Risk factors for chronic rejection in renal allograft recipients. Transplant. 1993;55(4):752–6. discussion 756-7. - PubMed
-
- Beisser PS, Lavreysen H, Bruggeman CA, Vink C. Chemokines and chemokine receptors encoded by cytomegaloviruses. Curr Top Microbiol Immunol. 2008;325:221–42. - PubMed
-
- Bissinger AL, Sinzger C, Kaiserling E, Jahn G. Human cytomegalovirus as a direct pathogen: correlation of multiorgan involvement and cell distribution with clinical and pathological findings in a case of congenital inclusion disease. J Med Virol. 2002;67(2):200–6. - PubMed
-
- Bouis D, Kusumanto Y, Meijer C, Mulder NH, Hospers GA. A review on pro- and anti-angiogenic factors as targets of clinical intervention. Pharmacol Res. 2006;53(2):89–103. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical